Showing results (41-50 of 1,026) with videos related to
Sort By:
Pageof 103
Disease Markers|February 28, 2007
MGMT methylation status: the advent of stratified therapy in glioblastoma?Peter Hau, Roger Stupp, Monika E HegiClinical Neurology and Neurosurgery|November 4, 2008
Pregabalin in patients with primary brain tumors and seizures: a preliminary observationJan Novy, Roger Stupp, Andrea O RossettiCancers|July 25, 2019
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?Begoña Alday-Parejo, Roger Stupp, Curzio RüeggChinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian HomicskoNeuro-Oncology|September 25, 2016
Tumor treating fields: a novel treatment modality and its use in brain tumorsAndreas F Hottinger, Patricia Pacheco, Roger StuppNeurosurgery Clinics of North America|November 23, 2020
Role of Resection in Glioblastoma ManagementMark W Youngblood, Roger Stupp, Adam M SonabendEuropean Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 9, 2004
Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinomaJürg Kutter, Mahmut Ozsahin, Philippe Monnier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical TrialsMonika E Hegi, Els Genbrugge, Thierry Gorlia, et al.Neuro-Oncology|April 16, 2005
Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until deathJean-Blaise Wasserfallen, Sandrine Ostermann, Serge Leyvraz, et al.Pageof 103